Bart Everaerdt

753 total citations
17 papers, 636 citations indexed

About

Bart Everaerdt is a scholar working on Immunology, Oncology and Cancer Research. According to data from OpenAlex, Bart Everaerdt has authored 17 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 6 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Bart Everaerdt's work include Immune Response and Inflammation (12 papers), NF-κB Signaling Pathways (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Bart Everaerdt is often cited by papers focused on Immune Response and Inflammation (12 papers), NF-κB Signaling Pathways (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Bart Everaerdt collaborates with scholars based in Belgium, United Kingdom and Switzerland. Bart Everaerdt's co-authors include Peter Brouckaert, Walter Fiers, Walter Fiers, Claude Libert, Nozomi Takahashi, Anje Cauwels, Jan Tavernier, Peter Vandenabeele, Xaveer Van Ostade and Hansruedi Loetscher and has published in prestigious journals such as Nature, Immunity and The Journal of Immunology.

In The Last Decade

Bart Everaerdt

17 papers receiving 602 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bart Everaerdt Belgium 12 366 209 108 106 78 17 636
Francisco Blanco-Favéla Mexico 18 451 1.2× 199 1.0× 93 0.9× 126 1.2× 49 0.6× 51 997
Jonathan T. Beech United Kingdom 13 316 0.9× 185 0.9× 111 1.0× 71 0.7× 59 0.8× 18 665
Yoshiaki Nemoto Japan 9 316 0.9× 110 0.5× 104 1.0× 61 0.6× 46 0.6× 10 603
Nobuhisa Nakamura Japan 12 264 0.7× 259 1.2× 69 0.6× 133 1.3× 48 0.6× 22 605
Su K. Seo South Korea 11 627 1.7× 145 0.7× 203 1.9× 85 0.8× 45 0.6× 14 911
Angela Santoni Italy 11 326 0.9× 110 0.5× 68 0.6× 47 0.4× 39 0.5× 11 610
Domenico Adorno Italy 20 498 1.4× 162 0.8× 327 3.0× 79 0.7× 62 0.8× 48 1.1k
Neelakshi R. Jog United States 15 375 1.0× 351 1.7× 167 1.5× 106 1.0× 46 0.6× 22 931
Kazuyoshi Watanabe Japan 14 349 1.0× 191 0.9× 135 1.3× 65 0.6× 105 1.3× 29 797
Jun Akaogi United States 12 285 0.8× 166 0.8× 75 0.7× 124 1.2× 30 0.4× 16 686

Countries citing papers authored by Bart Everaerdt

Since Specialization
Citations

This map shows the geographic impact of Bart Everaerdt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart Everaerdt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart Everaerdt more than expected).

Fields of papers citing papers by Bart Everaerdt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bart Everaerdt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart Everaerdt. The network helps show where Bart Everaerdt may publish in the future.

Co-authorship network of co-authors of Bart Everaerdt

This figure shows the co-authorship network connecting the top 25 collaborators of Bart Everaerdt. A scholar is included among the top collaborators of Bart Everaerdt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bart Everaerdt. Bart Everaerdt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Nogueira, D. M., R. Cortvrindt, Bart Everaerdt, & Johan Smitz. (2005). Effects of long-term in vitro exposure to phosphodiesterase type-3 inhibitors on follicle and oocyte development. Reproduction. 130(2). 177–186. 26 indexed citations
2.
Ameloot, Paul, Nozomi Takahashi, Bart Everaerdt, et al.. (2002). Bioavailability of recombinant tumor necrosis factor determines its lethality in mice. European Journal of Immunology. 32(10). 2759–2765. 11 indexed citations
3.
Cauwels, Anje, Wim Van Molle, Ben Janssen, et al.. (2000). Protection against TNF-Induced Lethal Shock by Soluble Guanylate Cyclase Inhibition Requires Functional Inducible Nitric Oxide Synthase. Immunity. 13(2). 223–231. 50 indexed citations
4.
Libert, Claude, Wim Van Molle, Tino Hochepied, et al.. (1997). INHIBITION OF TUMOR NECROSIS FACTOR-INDUCED LIVER TOXICITY AND LETHALITY BY THE ACUTE PHASE PROTEINS α-1-ACID GLYCOPROTEIN AND α-1-ANTITRYPSIN.. Shock. 7(Supplement). 65–65. 1 indexed citations
5.
Brouckaert, Peter, Claude Libert, Anje Cauwels, et al.. (1997). Inhibition of and sensitization to the lethal effects of tumor necrosis factor.. PubMed. 47(1-2). 18–26. 10 indexed citations
6.
Everaerdt, Bart, Peter Brouckaert, & Walter Fiers. (1994). Recombinant IL-1 receptor antagonist protects against TNF-induced lethality in mice.. The Journal of Immunology. 152(10). 5041–5049. 36 indexed citations
7.
Brouckaert, Peter, Paul Ameloot, Anje Cauwels, et al.. (1994). Receptor-selective mutants of tumour necrosis factor in the therapy of cancer: preclinical studies.. PubMed. 43(4). 185–90. 6 indexed citations
8.
Brouckaert, Peter, Claude Libert, Bart Everaerdt, et al.. (1993). Tumor necrosis factor, its receptors and the connection with interleukin 1 and interleukin 6. Immunobiology. 187(3-5). 317–329. 101 indexed citations
9.
Ostade, Xaveer Van, Peter Vandenabeele, Bart Everaerdt, et al.. (1993). Human TNF mutants with selective activity on the p55 receptor. Nature. 361(6409). 266–269. 153 indexed citations
10.
Libert, Claude, Anne Vink, Pierre G. Coulie, et al.. (1992). Limited involvement of interleukin‐6 in the pathogenesis of lethal septic shock as revealed by the effect of monoclonal antibodies against interleukin‐6 or its receptor in various murine models. European Journal of Immunology. 22(10). 2625–2630. 72 indexed citations
11.
Brouckaert, Peter, Bart Everaerdt, & Walter Fiers. (1992). The glucocorticoid antagonist RU38486 mimics interleukin‐1 in its sensitization to the lethal and interleukin‐6‐inducing properties of tumor necrosis factor. European Journal of Immunology. 22(4). 981–986. 28 indexed citations
12.
Brouckaert, Peter, Claude Libert, Bart Everaerdt, & Walter Fiers. (1992). Selective species specificity of tumor necrosis factor for toxicity in the mouse.. PubMed. 11(4). 193–6. 45 indexed citations
13.
Everaerdt, Bart, Peter Brouckaert, Alan Shaw, & Walter Fiers. (1989). Four different interleukin-1 species sensitize to the lethal action of Tumour Necrosis Factor. Biochemical and Biophysical Research Communications. 163(1). 378–385. 43 indexed citations
14.
Brouckaert, Peter, Bart Everaerdt, Claude Libert, Nozomi Takahashi, & Walter Fiers. (1989). Species specificity and involvement of other cytokines in endotoxic shock action of recombinant tumour necrosis factor in mice. Inflammation Research. 26(1-2). 196–198. 22 indexed citations
15.
Libert, Claude, et al.. (1989). A role for interleukin 1 in the in vivo actions of tumor necrosis factor.. PubMed. 8(3). 269–74. 17 indexed citations
16.
Fiers, Walter, Rudi Beyaert, Peter Brouckaert, et al.. (1988). TNF: its potential as an antitumour agent.. PubMed. 69. 143–51. 7 indexed citations
17.
Fiers, Walter, Rudi Beyaert, Peter Brouckaert, et al.. (1987). Gene cloning and structure - function relationship of cytokines such as TNF and interleukins. Immunology Letters. 16(3-4). 219–226. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francisco Blanco-Favéla Breakdown of academic impact, for papers by Jonathan T. Beech Breakdown of academic impact, for papers by Yoshiaki Nemoto Breakdown of academic impact, for papers by Nobuhisa Nakamura Breakdown of academic impact, for papers by Su K. Seo Breakdown of academic impact, for papers by Angela Santoni Breakdown of academic impact, for papers by Domenico Adorno Breakdown of academic impact, for papers by Neelakshi R. Jog Breakdown of academic impact, for papers by Kazuyoshi Watanabe Breakdown of academic impact, for papers by Jun Akaogi
Rankless by CCL
2026